KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Invested Capital (2019 - 2025)

Historic Invested Capital for Ginkgo Bioworks Holdings (DNA) over the last 7 years, with Q3 2025 value amounting to $559.8 million.

  • Ginkgo Bioworks Holdings' Invested Capital fell 2984.67% to $559.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $559.8 million, marking a year-over-year decrease of 2984.67%. This contributed to the annual value of $716.1 million for FY2024, which is 3473.48% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Invested Capital stood at $559.8 million, which was down 2984.67% from $613.0 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Invested Capital's 5-year high stood at $1.7 billion during Q4 2022, with a 5-year trough of $356.4 million in Q2 2021.
  • In the last 5 years, Ginkgo Bioworks Holdings' Invested Capital had a median value of $1.1 billion in 2023 and averaged $1.1 billion.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Invested Capital surged by 34112.6% in 2022, and later crashed by 4459.43% in 2024.
  • Ginkgo Bioworks Holdings' Invested Capital (Quarter) stood at $1.6 billion in 2021, then increased by 10.95% to $1.7 billion in 2022, then crashed by 36.91% to $1.1 billion in 2023, then tumbled by 34.73% to $716.1 million in 2024, then decreased by 21.82% to $559.8 million in 2025.
  • Its Invested Capital stands at $559.8 million for Q3 2025, versus $613.0 million for Q2 2025 and $647.4 million for Q1 2025.